Company to Highlight the Role of Precision Diagnostics in Transforming Rare and Undiagnosed Disease CareHOUSTON, Aug. 25, ...

The candidates are sourced from Arnatar’s next-gen RNA discovery engine, dubbed DARGER for dual-functional antisense RNA for ...

Arnatar is developing ART4, an antisense oligonucleotide that ups the expression of its target protein to treat a rare ...

DNA’s chemical cousin, RNA, was the messenger that carries DNA instructions from the double helix in the cell’s nucleus to ...

In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double ...

Sarepta is facing a number of issues currently, including platform-level safety concerns, management credibility issues, etc.

The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...

Over the last few years, scientists and entrepreneurs have flocked to developing medicines that target RNA, the genetic ...

In June, the monoclonal antibody garadacimab (Andembry) was approved for prevention of HAE attacks at a dose of once monthly ...

The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not ...

Dawnzera is the first and so far only RNA-targeting therapy approved as a prophylactic treatment for hereditary angioedema ...

A peer-reviewed study published in Scientific Reports, part of the Nature Portfolio, demonstrates a novel bioinformatic method for identifying messenger RNA (mRNA) biomarkers in stool that show high ...